Mediterranean-style Dietary Pattern (MDP), Mood and Anxiety

University of East Anglia25 enrolled

Overview

Observational studies and a limited numbers of RCTs have observed that habitual Mediterranean-style dietary pattern (MDP) consumption is associated with improved mental health and cognition. Yet, its efficacy in a short-term has not been studied in well-controlled intervention settings. MediMood is a cross-over RCT aiming to test whether a MDP can affect mood and anxiety following a meal (postprandial) and over 5-days in adults over 18 years with mild to moderate mental health problems relative to a Western diet (WD).

Depression, anxiety and age-related cognitive decline are leading global public health problems. A plant-based Mediterranean-style dietary pattern (MDP) includes olive oil as the main source of fat, fresh fruits, vegetables, seafood, legumes and nuts and a low consumption of red and processed meat, confectionary, and high-sugar drinks. A MDP promotes both physical and mental wellbeing and brain function. However, most studies to date have examined the impact of a MDP on health over months or years. As several underpinning biological mechanisms are likely to be responsive within hours or days, examining the short-term effect of a MDP on mental health outcomes is important. The overall goal of the present study is to understand the effects of a MDP on acute/sub-chronic brain health and its underpinning mechanisms. MediMood is a randomised cross-over efficacy trial. Participants will be assigned to an isocaloric MDP and a Western diet (WD) for 5-days in a random order with a 4-week wash-out period. All foods, meal plans and detailed dietary instructions will be provided. In addition to the primary outcome measures (mood and anxiety), the impact of intervention on cognitive performance, sleep, cerebral blood flow (MRI) and a selection of biomarkers of brain function will be measured in biological samples over five days. As low mood, anxiety and stress disorders affect daily functioning and reduce the quality of life significantly for many, the investigators believe the findings will have wide public health application.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Depression, Anxiety

Interventions

Mediterranean dietBEHAVIORAL

All foods, meal plans and instructions provided.

Western dietBEHAVIORAL

All foods, meal plans and instructions provided.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female, aged 18 or above * Is willing and able to comply with all study procedures, including changes in diets * Has access to and able to use the internet/computer/tablet device * Mild to moderate level of anxiety and/or depression symptoms, assessed by Generalised Anxiety disorder (GAD-7) score and Patient Health Questionnaire (PHQ-9), scores 5 to 14 on both questionnaires * A habitual MEDAS score of ≤ 7/14 * To be fluent in English Exclusion Criteria: * MEDAS score \>7 * Vegan/vegetarian * Allergies to one of the study components i.e. nuts, fish * On antidepressant or antianxiety medication where dosage is likely to change over the next 3 month * Factors precluding MRI scanning such as suffers from claustrophobia or has metal implants * Not fluent in English * Not agreement for the study team to contact the participants general practitioner about trial participation and screening results * Not prepared to make changes to the diet for 10 days (2 x 5 day periods)

Locations (1)

University of East Anglia

Norwich, Norfolk, United Kingdom

Outcomes

Primary Outcomes

Change in mood

Established by the Bond-Lader visual analogue scale (includes 16 items each having antonyms on two ends, on a scale of 1 to 100, 50 being the neutral point)

Time frame: Baseline (morning of day 1), Postprandial (after lunch on Established by the Bond-Lader visual analogue scale (includes 16 items each having day 1), 24-hours (morning of day 2), day 5 (morning of day 6 upon completion of 5 full days intervention)

Change in anxiety

Established by the Profile of Mood States (includes 65 items on a 5 point Likert scale)

Time frame: Baseline (morning of day 1), Postprandial (after lunch on day 1), 24-hours (morning of day 2), day 5 (morning of day 6 upon completion of 5 full days intervention)

Secondary Outcomes

Change in cognitive performance

Established by a neuropsychological test battery (https://neuropsychology.online) which assesses the following measures; attention, motor function, executive function, episodic memory, impulse control, visuospatial function

Time frame: Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)

Cerebral blood flow

Measured using MRI

Time frame: Postprandial day 1

Change in blood pressure

Measurements of brachial artery blood pressure (both diastolic and systolic pressure)

Time frame: Baseline (morning of day 1), Postprandial (after lunch on day 1), day 5 (morning of day 6 upon completion of 5 full days intervention)

Change in gut microbiota speciation

Faecal samples will be analysed for the gut microflora using 16sRNA sequencing.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.